Increased concentrations of free light chain lambda in sera from chronic hemodialysis patients.

No abstract is available for this paper.

• Publication year

  1991

• Venue

  Biomaterials Artificial Cells and Immobilization Biotechnology

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.3109/10731199109117819PMID 1751683
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Removal, generation and adsorption of beta-2-microglobulin during hemofiltration with five different membranes.

  1988cited by this paper
• Quantitation of free kappa light chains in serum and urine using a monoclonal antibody based inhibition enzyme-linked immunoassay.

  1987cited by this paper
• In vitro formation of amyloid fibrils from intact beta 2-microglobulin.

  1985cited by this paper
• A new form of amyloid protein associated with chronic hemodialysis was identified as beta 2-microglobulin.

  1985cited by this paper
• Beta-2 microglobulin is an amyloidogenic protein in man.

  1985cited by this paper
• Light-chain deposition disease: its relation with AL-type amyloidosis.

  1984cited by this paper
• Liver involvement in nonamyloid light chain deposits disease.

  1984cited by this paper
• Renal granular monoclonal light chain deposits: morphological aspects in 11 cases.

  1984cited by this paper
• Kappa light chain nephropathy without evidence of myeloma cells. Response to chemotherapy with cessation of maintenance hemodialysis.

  1982cited by this paper
• Amyloid production in human myeloma stem-cell culture, with morphologic evidence of amyloid secretion by associated macrophages.

  1982cited by this paper
• Free light chains of immunoglobulins.

  1981cited by this paper
• A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

  1976cited by this paper
• Manifestations of systemic light chain deposition.

  1976cited by this paper
• The Kidney in systemic disease

  1976cited by this paper
• Renal removal of low molecular weight proteins in myeloma and renal transplant patients.

  1974cited by this paper
• Evidence for defective immunoglobulin metabolism in severe renal insufficiency

  1974cited by this paper
• Time course of labeling of light and heavy chains of immunoglobulin G and the turnover of the free light-chain intermediates.

  1968cited by this paper
• Balanced Synthesis of Light and Heavy Chains of Immunoglobulin G

  1967cited by this paper
• Synthesis of Excess Light Chains of Gamma Globulin by Rabbit Lymph Node Cells

  1966cited by this paper

• Hemodiafiltration improves free light chain removal and normalizes κ/λ ratio in hemodialysis patients

  2016cites this paper
• Free immunoglobulin light chain: its biology and implications in diseases.

  2011cites this paper
• Trial use of a polymethylmethacrylate membrane for the removal of free immunoglobulin light chains in dialysis patients

  2010cites this paper
• Inconsistency of reported uremic toxin concentrations.

  2007cites this paper
• Uremia impairs blood dendritic cell function in hemodialysis patients.

  2007cites this paper
• Immunochemical quantification of free immunoglobulin light chains from an analytical perspective

  2006cites this paper
• Effect of Immunoglobulin Light Chains from Hemodialysis and Continuous Ambulatory Peritoneal Dialysis Patients on Polymorphonuclear Leukocyfe

  2005cites this paper
• Immunoglobulin light chains modulate polymorphonuclear leucocyte apoptosis

  2003cites this paper
• Immunoglobulin light chains in uremia.

  2003cites this paper
• Effect of dialysis on serum/plasma levels of free immunoglobulin light chains in end-stage renal disease patients.

  2002influential citation
• Highly sensitive, automated immunoassay for immunoglobulin free light chains in serum and urine.

  2001influential citation
• Uremic toxins modulate the spontaneous apoptotic cell death and essential functions of neutrophils.

  2001cites this paper
• Uremic Toxicity: Present State of the Art

  2001cites this paper
• Clinical significance of granulocyte-inhibiting proteins.

  2000cites this paper
• High molecular weight uremic toxins

  1998cites this paper
• Immune dysfunction in uremia.

  1997cites this paper
• Dysfunction of polymorphonuclear leukocytes in uremia.

  1996cites this paper
• [The clinical significance of free light-chain immunoglobulins].

  1996cites this paper
• Are granulocyte inhibitory proteins contributing to enhanced susceptibility to infections in uraemia?

  1996cites this paper
• [A new approach to the determining immunoglobulin free light chains in serum by TIA nephelometry].

  1996cites this paper
• Effect of immunoglobulin light chains from hemodialysis and continuous ambulatory peritoneal dialysis patients on polymorphonuclear leukocyte functions.

  1995cites this paper
• Immunoglobulin free light chain assay using latex agglutination

  1995cites this paper